{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:31:13Z","timestamp":1790706673443,"version":"4.1.0"},"reference-count":15,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T00:00:00Z","timestamp":1559692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100009053","name":"The Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/M\/12\/500261"],"award-info":[{"award-number":["IA\/M\/12\/500261"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The feasibility of bortezomib (BZB) in induction and reduced cytarabine doses in intensification was evaluated in children with relapsed acute lymphoblastic leukaemia (rALL) at a single centre in India. Of 55 children with rALL, 23 received supportive care and 7 refused treatment, with a median survival of 2 (interquartile range 1\u20136) months. Twenty\u2010two (88%) of 25 children who were treated achieved second remission and 9 (69%) of 13 had end\u2010of\u2010induction minimal residual disease of &lt;10<jats:sup>\u22124<\/jats:sup>. The lower cytarabine dose was associated with decreased hospitalisation. One\u2010year event\u2010free and overall survival for the treated group was 74\u00b77% (95% confidence interval 52\u201388) and 79\u00b76% (58\u201391) respectively.<\/jats:p>","DOI":"10.1111\/bjh.16005","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T03:56:07Z","timestamp":1559793367000},"page":"861-865","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy and safety of a bortezomib and reduced\u2010intensity cytarabine\u2010based protocol, TMC ALLR1, for relapsed childhood ALL in India"],"prefix":"10.1111","volume":"186","author":[{"given":"Prakriti","family":"Roy","sequence":"first","affiliation":[{"name":"Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubina","family":"Islam","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debparna","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manash","family":"Gogoi","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Kumar Mishra","sequence":"additional","affiliation":[{"name":"Department of Cytogenetics and Laboratory Haematology Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Arora","sequence":"additional","affiliation":[{"name":"Department of Cytogenetics and Laboratory Haematology Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Parihar","sequence":"additional","affiliation":[{"name":"Department of Cytogenetics and Laboratory Haematology Tata Medical Centre Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India"},{"name":"Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2916-9649","authenticated-orcid":false,"given":"Vaskar","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology Oncology Tata Translational Cancer Research Centre, Tata Medical Centre Kolkata India"},{"name":"Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health University of Manchester Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,6,5]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14505"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294983"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163090"},{"key":"e_1_2_4_5_1","first-page":"1","article-title":"FxCycle based ploidy correlates with cytogenetic ploidy in B\u2010cell acute lymphoblastic leukemia and is able to detect the aneuploid minimal residual disease clone","author":"Gupta N.","year":"2019","journal-title":"Cytometry Part B: Clinical Cytometry"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15919"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15233"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010222"},{"key":"e_1_2_4_10_1","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1182\/blood.V126.23.1414.1414","article-title":"Validation of MRD quantification by flow cytometry for pediatric BCP ALL relapsed patients treated on the intreall protocol","volume":"126","author":"Mejstrikova E.","year":"2015","journal-title":"Blood"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-418640"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62002-8"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30003-1"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.16694"},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21486"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404586"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.16005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjh.16005","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.16005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T23:16:01Z","timestamp":1694301361000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.16005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,5]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1111\/bjh.16005"],"URL":"https:\/\/doi.org\/10.1111\/bjh.16005","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,5]]},"assertion":[{"value":"2019-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-05","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}